The identification of 38 mutations that were not known to be part of the mutations affecting the Israeli population, and the understanding of the potential benefit of expanded preconception screening using a well‐curated list of CF‐causing mutations could lead to a revision of the CFTR screening panel currently suggested in Israel. Here, CFTR is linked to cystic fibrosis.